The Alzheimer’s Drug Discovery Foundation (ADDF) and the Harrington Discovery Institute are calling for proposals for their 2017 ADDF-Harrington Scholar Award, which supports innovative research that aims to prevent, treat or cure Alzheimer’s disease (AD). Applicants are eligible to receive financial support over two years of up…
Honor is collaborating with the Alzheimer’s Association to educate its Care Pros on how to better care for people living with Alzheimer’s disease. Start-up company Honor offers tech-powered home care for older adults. The new agreement follows similar collaborations, such as the National Parkinson Foundation and the American Cancer Society.
Neither high cholesterol intake nor daily egg consumption increases the risk of dementia or Alzheimer’s disease (AD), according to a study of Finnish men. In fact, moderate egg intake may improve cognitive performance, researchers said. The study also showed no link between men with the APOE4 gene and the development…
Researchers at Rush and Harvard universities are preparing a pioneering clinical trial to evaluate the impact of diet in preventing cognitive decline and Alzheimer’s disease (AD) in older people. The randomized Phase 3 trial (NCT02817074), titled “MIND Diet Intervention and Cognitive Decline,” will test whether a healthy diet…
Pharnext is reporting positive Phase 2 results from its investigative pleodrug PXT-864, a new oral combination of existing therapies, for the treatment of Alzheimer’s disease. Results from the exploratory study were presented at the 9th Clinical Trials on Alzheimer’s Disease (CTAD) meeting, held recently in San Diego. PLEODIAL-I (NCT02361424) was a Phase 2, 12-week…
Researchers have found that 75% of older adults would take a free and definitive test predictive of Alzheimer’s disease (AD), if such a test existed. The study with the findings, “Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study,” was published…
Proclara Biosciences has announced two additional patents in its effort to develop therapies for neurodegenerative diseases such as Alzheimer’s that have been linked to protein misfolding. A key step in the biotech company’s approach to treating these diseases was discovering a protein motif which recognizes that several toxic…
Two years of in-home occupational therapy, added to collaborative care, did not slow the rate of functional decline — the progressive loss of cognitive, emotional, and physical abilities — in patients with Alzheimer disease (AD), a new study reported. The study, “Targeting Functional Decline in Alzheimer Disease: A Randomized Trial,” was published…
A new research study has found that the use of benzodiazepines and related drugs increases the risk of hip fracture by 43 percent in people with Alzheimer’s disease. The study was conducted in community-dwelling Finnish people with Alzheimer’s who were evaluated for their hip fracture risk. The results of…
A study led by Finnish researchers found that long-term use of opioids, painkillers that can be addictive, is common among people in that country with Alzheimer’s disease (AD), but at rates similar to people match by age, gender, and region of residence. The study, “Long-term use of opioids for non-malignant pain…
Get regular updates to your inbox.